Worley Julie
Julie Worley, PhD, FNP-BC, PMHNP-BC, CARN-AP, Associate Professor, Rush University, and Clinical Practice, Rosecrance, Chicago, IL.
Orthop Nurs. 2019 Mar/Apr;38(2):129-135. doi: 10.1097/NOR.0000000000000524.
Opioids are commonly prescribed in orthopaedics for acute or chronic pain for a variety of conditions, including injury, trauma, degenerative processes, and postsurgical. Patients who are taking opioids because of a substance use disorder (SUD) are also seen in orthopaedics. Patients who are prescribed opioids are at risk of developing an opioid use disorder (OUD). Ten percent of Americans will develop an SUD, which is considered a chronic medical condition that develops due to an imbalance in brain chemistry. In studies, orthopaedic surgeons have a high rate of prescribing opioids, but this rate is decreasing along with national average due to public and provider awareness of the opioid epidemic and professional recommendations. Despite the evidence of a neurobiological cause for SUDs, stigma toward patients with SUDs and a knowledge deficit are common among healthcare professionals, including orthopaedic nurses. A harm reduction approach when working with orthopaedic patients taking opioids either prescribed or used because of an OUD can be applied to reduce the problematic effects of opioids. Harm reduction strategies are supportive to the patient and include education and prevention, adopting evidence-based treatment and communication strategies, and the use of naloxone to prevent opioid overdose.
在骨科领域,阿片类药物常用于治疗各种急慢性疼痛,包括损伤、创伤、退行性病变以及术后疼痛等。因物质使用障碍(SUD)而服用阿片类药物的患者在骨科中也较为常见。开具阿片类药物处方的患者有患阿片类药物使用障碍(OUD)的风险。10%的美国人会患上物质使用障碍,这被认为是一种由于大脑化学失衡而引发的慢性疾病。在研究中,骨科医生开具阿片类药物的比例较高,但由于公众和医疗服务提供者对阿片类药物流行问题的认识以及专业建议,这一比例正随着全国平均水平下降。尽管有证据表明物质使用障碍存在神经生物学病因,但包括骨科护士在内的医护人员对患有物质使用障碍的患者存在污名化现象且知识匮乏。对于因阿片类药物使用障碍而服用处方阿片类药物或自行使用阿片类药物的骨科患者,采用减少伤害的方法可减轻阿片类药物的不良影响。减少伤害策略对患者具有支持作用,包括教育与预防、采用循证治疗和沟通策略以及使用纳洛酮预防阿片类药物过量。